Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predominant Sensitizations to Single Bee Venom Allergens as a Risk Factor for Therapy Failure

NCT04259359 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.

NCT NCT04259359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04259359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predominant Sensitizations to Single Bee Venom Allergens as a Risk Factor for Therapy Failure
Lead sponsor
Medical University of Graz
Phase
Observational
Overall status
Recruiting
Start date
May 2, 2019
Completion date
March 31, 2029
Enrollment
266 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

bee venom allergy